Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today hosted its ...
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and ...
Constantine Davides, an analyst from JMP Securities, has initiated a new Hold rating on Simulations Plus (SLP). Constantine Davides has given his Hold rating due to a combination of factors including ...
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma ...
The MarketWatch News Department was not involved in the creation of this content. Together, the simulation-based training leaders advance a shared mission to elevate operator productivity, safety, and ...
RESEARCH TRIANGLE PARK, N.C., January 21, 2026--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results